Found: 19
Select item for more details and to access through your institution.
Relations of perceived injustice to psycho‐spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 12, p. 2177, doi. 10.1002/pon.6065
- By:
- Publication type:
- Article
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 2, p. 213, doi. 10.1016/j.clgc.2023.01.004
- By:
- Publication type:
- Article
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1087, doi. 10.1007/s10637-022-01276-w
- By:
- Publication type:
- Article
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1656, doi. 10.1007/s10637-021-01134-1
- By:
- Publication type:
- Article
Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol.
- Published in:
- Reports of Practical Oncology & Radiotherapy, 2020, v. 25, n. 4, p. 500, doi. 10.1016/j.rpor.2020.04.007
- By:
- Publication type:
- Article
Differential Effects of Gefitinib and Cetuximab on Non—small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 16, p. 1185, doi. 10.1093/jnci/dji238
- By:
- Publication type:
- Article
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Prognostic Factors in Stage III Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Cancer Update, 2007, v. 1, n. 1, p. 63, doi. 10.3816/CCU.2007.n.010
- By:
- Publication type:
- Article
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0250285
- By:
- Publication type:
- Article
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 156, doi. 10.1002/cam4.3583
- By:
- Publication type:
- Article
Computer-Tailored Decision Support Tool for Lung Cancer Screening: Community-Based Pilot Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Review: Advanced non-small cell lung cancer: the role of maintenance therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 1, p. 17, doi. 10.1177/1758834009351443
- By:
- Publication type:
- Article
Antimetabolites in the management of non-small cell lung cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non–Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 47, doi. 10.1093/oncolo/oyad180
- By:
- Publication type:
- Article
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non–small cell lung cancer previously treated with a PD‐1 or PD‐L1 inhibitor: Big Ten Cancer Research Consortium BTCRC‐LUN15‐029.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 264, doi. 10.1002/cncr.34565
- By:
- Publication type:
- Article
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 20, p. 3751, doi. 10.1002/cncr.33771
- By:
- Publication type:
- Article
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
- Published in:
- 2020
- By:
- Publication type:
- journal article